A new analysis of the STEP trails carried out by semaglutide manufacturer Novo Nordisk has analysed various trials to show the safety and efficacy of the obesity drug semaglutide in…

A new study presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that a 1% reduction in annual working hours is associated with…

An essay presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) suggests that new age of obesity drugs could shift the blame for living with obesity…

A Virginia Tech disease ecologist said the outbreak of Andes hantavirus aboard the international MV Hondius cruise ship underscores how little scientists still know about the viruses circulating silently in…

For babies born to people with endometriosis, there is a small but significant increased risk of congenital anomalies, often called birth defects, according to new research in CMAJ (Canadian Medical…

A longitudinal study of 307 Filipino fathers found that COVID-19 lockdowns did not produce lasting increases in paternal caregiving, with routine care actually declining post-pandemic. Shifts in employment status emerged…

A study using a nationally representative survey of parents in England, to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May), reveals that over…

New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that, following treatment for obesity or diabetes or both using incretin-based…

The closest-ever detailed look at a key enzyme inside the virus that causes COVID-19 could lead to more effective treatment of the disease.

Heart disease risk has been found to increase in women with polycystic ovary syndrome (PCOS), even in those with normal weight, according to research presented at the 28th European Congress…